CGON: the cashflow

MyFinsight

For the quarter ending 2025-09-30, CGON had $30,521K increase in cash & cash equivalents over the period. -$38,991K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Accounts receivable - other	-	-219
Net loss	-43,808	-75,878
Depreciation and amortization	416	180
Stock-based compensation expense	7,331	12,158
Accretion of discount on short-term investments	-201	2,166
Non-cash interest income	169	675
Non-cash lease expense	8	13
Prepaid expenses and other current assets	105	-15
Accounts receivable, net	19	-
Other assets	7	13
Accounts payable	1,227	608
Accrued expenses and other current liabilities	-3,379	8,303
Inventory	380	-
Other liabilities	9	-
Net cash used in operating activities	-38,894	-57,236
Proceeds from sales and maturities of investments	621,899	-
Proceeds from sales and maturities of short-term investments	-	370,520
Purchases of investments	770,122	-
Purchases of short-term investments	-	529,852
Acquisition, net of cash acquired	21,967	-
Purchases of property and equipment	97	30
Issuance of note receivable	-	26,000
Net cash used in investing activities	15,045	-185,362
Proceeds from at-the-market offering, net of issuance costs	49,001	-
Proceeds from exercise of common stock options and issuance of common stock under the employee stock purchase plan	5,099	701
Deferred offering costs	270	-547
Net cash provided by financing activities	54,370	154
Net (decrease) increase in cash and cash equivalents	30,521	-242,444
Cash and cash equivalents at beginning of period	257,068	-
Cash and cash equivalents at end of period	45,145	-

Unit: Thousand (K) dollars